PORTFOLIO
PORTFOLIO COMPANIES
tella, Inc. (Exited)
COMPANY PROFILE
Transferring technology related to cancer dendritic cell vaccine therapy to medical institutions, etc
Tella has enhanced the efficiency and usability of dendritic cell vaccination therapy, with little to no side effects. Their therapeutic methods were developed at the Institute of Medical Science of the University of Tokyo. Tella’s mission is to improve their therapy technology to make it more accessible to cancer patients, supporting clinics, hospitals and medical institutes.
